473732-87-5

Basic information

• Product Name: Benzenemethanamine, alpha-cyclopropyl-4-fluoro-, (alphaR)- (9CI)
• Synonyms: Benzenemethanamine, alpha-cyclopropyl-4-fluoro-, (alphaR)- (9CI);N-(4-Fluorobenzyl)cyclopropanamine hydrochloride;R-cyclopropyl(4-fluorophenyl)MethanaMine-HCl;(1R)CYCLOPROPYL(4-FLUOROPHENYL)METHYLAMINE-HCl;(1R)-Cyclopropyl-(4-fluorophenyl)MethylaMine hydrochloride;-Cyclopropyl(4-fluorophenyl)
• CAS NO: 473732-87-5
• Molecular Formula: C10H12FN
• Molecular Weight: 165.2073832
• Product Categories: HALIDE
• Mol File: 473732-87-5.mol

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C(protect from light)
• CAS DataBase Reference: Benzenemethanamine, alpha-cyclopropyl-4-fluoro-, (alphaR)- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenemethanamine, alpha-cyclopropyl-4-fluoro-, (alphaR)- (9CI)(473732-87-5)
• EPA Substance Registry System: Benzenemethanamine, alpha-cyclopropyl-4-fluoro-, (alphaR)- (9CI)(473732-87-5)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 473732-87-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Research:
Benzenemethanamine, alpha-cyclopropyl-4-fluoro-, (alphaR)(9CI) is used as a research compound for exploring its potential in drug development. Its unique structure and functional groups may offer insights into new therapeutic agents or contribute to the understanding of molecular interactions in biological systems.
Used in Chemical Synthesis:
In the field of chemical synthesis, Benzenemethanamine, alpha-cyclopropyl-4-fluoro-, (alphaR)(9CI) is used as an intermediate or a building block in the preparation of more complex molecules. Its presence in the synthesis process can lead to the creation of novel compounds with specific properties and applications.
Used in Laboratory Settings:
Benzenemethanamine, alpha-cyclopropyl-4-fluoro-, (alphaR)(9CI) is used as a reagent or a reference material in laboratory experiments. Its distinct chemical properties may be essential for certain analytical techniques or for comparing with other compounds in research studies.
Note: The specific applications mentioned above are hypothetical and are based on the general nature of the compound. The actual uses may vary depending on the context and the specific requirements of the industry or research field.

Upstream product

• 705-14-6 α-cyclopropyl-4-fluorobenzylamine 

Relevant articles and documents

AMINE DERIVATIVES AS POTASSIUM CHANNEL BLOCKERS

The present invention relates to compounds useful in the modulation of potassium channel activity in cells, in particular the activity of Kv1.3 channels found in T cells. The invention also relates to the use of these compounds in the treatment or prevention of autoimmune and inflammatory diseases, including multiple sclerosis, pharmaceutical compositions containing these compounds and methods for their preparation.

THIADIAZOLEDIOXIDES AND THIADIAZOLEOXIDES AS CXC- AND CC-CHEMOKINE RECEPTOR LIGANDS

Disclosed are novel compounds of the formula (IA) and the pharmaceutically acceptable salts and solvates thereof. Examples of groups comprising Substituent A include heteroaryl, aryl, heterocycloalkyl, cycloalkyl, aryl, alkynyl, alkenyl, aminoalkyl, alkyl or amino. Examples of groups comprising Substituent B include aryl and heteroaryl. Also disclosed is a method of treating a chemokine mediated diseases, such as, cancer, angiogenisis, angiogenic ocular diseases, pulmonary diseases, multiple sclerosis, rheumatoid arthritis, osteoarthritis, stroke and cardiac reperfusion injury, acute pain, acute and chronic inflammatory pain, and neuropathic pain using a compound of formula (IA).

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.